These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1474447)

  • 1. Standardization of antifungal susceptibility testing.
    Galgiani JN; Rinaldi MG; Polak AM; Pfaller MA
    J Med Vet Mycol; 1992; 30 Suppl 1():213-24. PubMed ID: 1474447
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility testing of medically important fungi.
    Merz WG
    Adv Exp Med Biol; 1986; 202():127-34. PubMed ID: 3788693
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility testing of fungi: current status of the standardization process.
    Galgiani JN
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2517-21. PubMed ID: 8109912
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro antifungal susceptibility testing and measurement of levels of antifungal agents in body fluids.
    Drutz DJ
    Rev Infect Dis; 1987; 9(2):392-7. PubMed ID: 3296103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microbial sensitivity tests with antifungal agents and their determination in body fluids].
    Vazzana A
    Quad Sclavo Diagn; 1981 Mar; 17(1):115-22. PubMed ID: 7313067
    [No Abstract]   [Full Text] [Related]  

  • 6. Standardization of antifungal susceptibility testing and clinical relevance.
    Espinel-Ingroff A; Barchiesi F; Hazen KC; Martinez-Suarez JV; Scalise G
    Med Mycol; 1998; 36 Suppl 1():68-78. PubMed ID: 9988494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal susceptibility testing.
    Fothergill AW; Rinaldi MG; Sutton DA
    Infect Dis Clin North Am; 2006 Sep; 20(3):699-709. PubMed ID: 16984876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal drug susceptibility testing. A critical review.
    Stevens DA
    Mycopathologia; 1984 Sep; 87(3):135-40. PubMed ID: 6392886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
    Gómez-López A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
    J Antimicrob Chemother; 2001 Dec; 48(6):919-21. PubMed ID: 11733480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Standardization of the fungistasis diffusion test].
    Böhm W
    Dermatol Monatsschr; 1969; 155(7):504-6. PubMed ID: 4989817
    [No Abstract]   [Full Text] [Related]  

  • 11. [Colorimetric broth microdilution for antifungal susceptibility testing].
    Yamane N; Tosaka M; Okazawa Y
    Rinsho Byori; 1996 Jan; 44(1):67-75. PubMed ID: 8691643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory tests of antifungal drugs in treatment of systemic mycoses.
    Holmberg K
    Scand J Infect Dis Suppl; 1978; (16):65-73. PubMed ID: 373080
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs.
    Caligiorne RB; Resende MA; Melillo PH; Peluso CP; Carmo FH; Azevedo V
    Med Mycol; 1999 Dec; 37(6):405-9. PubMed ID: 10647121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibility testing: practical aspects and current challenges.
    Rex JH; Pfaller MA; Walsh TJ; Chaturvedi V; Espinel-Ingroff A; Ghannoum MA; Gosey LL; Odds FC; Rinaldi MG; Sheehan DJ; Warnock DW
    Clin Microbiol Rev; 2001 Oct; 14(4):643-58, table of contents. PubMed ID: 11585779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization of antifungal susceptibility testing.
    Cormican MG; Pfaller MA
    J Antimicrob Chemother; 1996 Oct; 38(4):561-78. PubMed ID: 8937952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.
    Arendrup MC; Meletiadis J; Mouton JW; Guinea J; Cuenca-Estrella M; Lagrou K; Howard SJ;
    Clin Microbiol Infect; 2016 Jun; 22(6):571.e1-4. PubMed ID: 26851656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal susceptibility testing: progress and future developments.
    Pfaller MA
    Braz J Infect Dis; 2000 Apr; 4(2):55-60. PubMed ID: 11012296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal resistance in opportunistic pathogenic fungi (I). Polyenes and fluorocytosine].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996; 14(6):384-9. PubMed ID: 8756218
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility testing methods of antifungal agents.
    Ernst EJ
    Methods Mol Med; 2005; 118():3-12. PubMed ID: 15888930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.